68GaFAPI-46 PET/CT for Pancreatic Ductal Adenocarcinoma

Overview

About this study

The purpose of this study is to examine the utility of 68GaFAPI-46 PET/CT imaging in adult patients with biopsy-proven Pancreatic Ductal Adenocarcinoma (PDA) who have no prior treatment for their PDA and who are expected to undergo surgical resection following NAT. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- Adults > 18 years (yrs.) with treatment-naive biopsy-proven PDA or with findings
diagnostic for PDA on baseline imaging (CT, MRI, or PET)

- Localized disease expected to undergo surgical resection following neoadjuvant therapy
(NAT)

- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2

- Ability to provide informed consent

Exclusion Criteria:

- Hypersensitivity to any excipients in 68Ga-FAPI-46

- Require emergency surgery

- Non-PDA histology on biopsy

- Histopathologically proven metastatic PDA

- Pregnant women

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 12/30/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ajit Goenka, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Maggie Olson

Olson.Maggie@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions